المؤلفون: Steven P. Angus (5536277), Timothy J. Stuhlmiller (10529720), Gaurav Mehta (433872), Samantha M. Bevill (10529722), Daniel R. Goulet (10529724), J. Felix Olivares-Quintero (10529727), Michael P. East (4029053), Maki Tanioka (411765), Jon S. Zawistowski (10529729), Darshan Singh (8962952), Noah Sciaky (75812), Xin Chen (14149), Xiaping He (17167), Naim U. Rashid (7495055), Lynn Chollet-Hinton (3467606), Cheng Fan (17164), Matthew G. Soloway (10529732), Patricia A. Spears (10529733), Stuart Jefferys (10529734), Joel S. Parker (9865554), Kristalyn K. Gallagher (10529736), Andres Forero-Torres (4423138), Ian E. Krop (9594454), Alastair M. Thompson (7957970), Rashmi Murthy (6597207), Michael L. Gatza (6670643), Charles M. Perou (9743776), H. Shelton Earp (251553), Lisa A. Carey (10529739), Gary L. Johnson (363110)

مصطلحات موضوعية: Cancer, Oncology and Carcinogenesis not elsewhere classified, Biological Sciences not elsewhere classified, Tumour heterogeneity, breast cancer, HER3/ERBB3, trastuzumab, pertuzumab, lapatinib, LCCC1214

Relation: https://figshare.com/articles/dataset/Metadata_record_for_the_manuscript_FOXA1_and_adaptive_response_determinants_to_HER2_targeted_therapy_in_TBCRC_036/14376746

الاتاحة: https://doi.org/10.6084/m9.figshare.14376746.v1